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Background: Physical activity is believed to exert a beneficial effect on functional and cognitive rehabilitation of patients
with stroke. Although studies have addressed the impact of physical exercise in cerebrovascular prevention and
rehabilitation, the underlying mechanisms leading to improvement are poorly understood. Training-induced increase of
cerebral perfusion is a possible mediating mechanism. Our exploratory study aims to investigate training-induced
changes in blood biomarker levels and magnetic resonance imaging in patients with subacute ischemic stroke.
Methods/design: This biomarker-driven study uses an observational design to examine a subgroup of patients in the
randomized, controlled PHYS-STROKE trial. In PHYS-STROKE, 215 patients with subacute stroke (hemorrhagic and
ischemic) receive either 4 weeks of physical training (aerobic training, 5 times a week, for 50 minutes) or 4 weeks of
relaxation sessions (5 times a week, for 50 minutes). A convenience sample of 100 of these patients with ischemic stroke
will be included in BAPTISe and will receive magnetic resonance imaging (MRI) scans and an additional blood draw
before and after the PHYS-STROKE intervention. Imaging scans will address parameters of cerebral perfusion, vessel size
imaging, and microvessel density (the Q factor) to estimate the degree of neovascularization in the brain. Blood tests will
determine several parameters of immunity, inflammation, endothelial function, and lipometabolism. Primary objective of
this study is to evaluate differential changes in MRI and blood-derived biomarkers between groups. Other endpoints are
next cerebrovascular events and functional status of the patient after the intervention and after 3 months assessed by
functional scores, in particular walking speed and Barthel index (co-primary endpoints of PHYS-STROKE). Additionally, we
will assess the association between functional outcomes and biomarkers including imaging results. For all endpoints we
will compare changes between patients who received physical fitness training and patients who had relaxation sessions.
Discussion: This exploratory study will be the first to investigate the effects of physical fitness training in patients with
ischemic stroke on MRI-based cerebral perfusion, pertinent blood biomarker levels, and functional outcome. The study
may have an impact on current patient rehabilitation strategies and reveal important information about the roles of MRI
and blood-derived biomarkers in ischemic stroke.
Trial registration: NCT01954797.
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The importance of physical exercise in cardiovascular
disease prevention is evident [1,2]. Physical fitness can
mitigate clinically relevant risk factors including hyper-
tension, diabetes mellitus, or dyslipidemia [3]. Physical
exercise may also be favorable in primary and secondary
prevention of cerebrovascular diseases and cognitive
impairment [4]. Large prospective cohort studies have
highlighted the association of midlife fitness levels and
lower hazard ratios of developing later-life dementia; it
has been shown that physical activity has beneficial ef-
fects on structural brain integrity [5-7]. Aerobic fitness
training was indicated to have a positive impact on the
functional outcome of patients with stroke [8,9]. How-
ever, the underlying mechanisms leading to improved
clinical rehabilitation are not well understood and there
is need for further studies adding information to the
growing evidence [4,8].
The change of cerebral perfusion following physical
activity could be one possible mechanism to explain the
observed clinical improvement in patients. Impaired
cerebrovascular reactivity has been associated with vari-
ous conditions including age, white matter lesion path-
ology, cognitive impairment, and risk of stroke [10-12].
Resting cerebral blood flow declines with age [13] and
endurance exercise-trained men show increased cere-
bral blood flow velocity compared to sedentary men of
same age [14,15]. More recent studies have underscored
the positive effects of physical exercise in healthy indi-
viduals and chronic stroke patients; they have linked the
effects to improved cerebral perfusion and autoregula-
tion [16,17]. In addition, current magnetic resonance
imaging (MRI) scans using vessel size imaging enable
in vivo assessment of cerebral perfusion, microvascular
morphology, and cerebral angiogenesis; hence providing
promising information about vascular remodeling,
neural plasticity, and cerebral (neo)vascularization after
stroke [18,19].
Preclinical studies have shown beneficial effects of
physical exercise on long-term stroke outcome in ro-
dents. These outcomes were associated with increased
basal cerebral blood flow and improved endothelial
function as well as angiogenesis [20-22]. Other animal
studies have reported that certain serum biomarkers
strongly correlate with functional outcome after stroke
[23,24]. In humans, presence of different blood bio-
markers including stress and immune markers are
known to have a negative prognostic value on the out-
come of patients with ischemic stroke [25-27]. Investi-
gations on the influence of physical activation and
exercise on immunity revealed conflicting results.
Whether or not pertinent blood biomarker levels can be
positively influenced by physical exercise post stroke
has not been investigated so far.A better understanding of physical training-induced
changes in cerebral perfusion and cerebral microvascula-
ture in correlation with alterations of specific serum bio-
marker levels and functional status of patients would
have a considerable effect on stroke prevention, rehabili-
tation and could lead to new therapeutic strategies.
Methods/design
Setting
“Biomarkers And Perfusion – Training-Induced changes
after Stroke” (NCT01954797) is a prospective, endpoint-
blinded observational study accompanying a randomized,
controlled trial called Physical Fitness Training in Sub-
acute Stroke (NCT01953549). Out of all PHYS-STROKE
participants, only patients with ischemic stroke are eligible
for BAPTISe. Patients will be recruited at six different par-
ticipating rehabilitation sites in the Berlin area. Recruit-
ment will start in October 2013 and will continue for
30 months in total. Follow-up visits are planned at 3 and
6 months post stroke. The duration of the study will be
36 months in total. Research is carried out in compliance
with the Helsinki Declaration and received ethical ap-
proval of the local authorities (Ethics Commission of the
Charité, EA1/137/13).
Although this study is accompanying a randomized con-
trolled trial we consider it to be similar to a prospective
observational study where the physical training is the
exposure. Reasons for this are:
– The PHYS-STROKE trial is designed for different
outcomes (functional outcomes) than the BAPTISe
study.
– Not all patients from PHYS-STROKE will be included
in BAPTISe. We will use convenience sampling from
participants in the trial. In sensitivity analysis we will
test whether the subgroup of patients in BAPTISe
differs from those patients in PHYS-STROKE
eligible for BAPTISe but not included in BAPTISe.
– The analysis of the endpoints (MRI and blood
biomarkers) is exploratory insofar as this study tries
to identify potential candidates of MRI measures
and blood biomarkers that are associated with
physical training in subacute ischemic stroke
patients after adjustment for possible confounders.
We aim to determine specific changes in the blood
and the cerebral vasculature of patients with subacute
ischemic stroke who perform 4 weeks of aerobic fitness
training in comparison to patients who receive 4 weeks
of relaxation sessions. Serum levels of multiple blood
biomarkers including parameters of immunity, inflamma-
tion, endothelial function, and lipometabolism will be
assessed from all patients enrolled in PHYS-STROKE.
Blood draws will also be performed at follow-up visits
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Blood-derived biomarkers assessed are listed in Table 1.
Patients who also enrolled in BAPTISe will have an MRI
scan and an additional blood draw for the assessment of
certain markers of endothelial function in the vicinity of
the MR scanner before and after the intervention. Using
MRI we will assess various parameters of cerebral perfu-
sion measuring cerebral blood flow (CBF) and cerebral
blood volume (CBV), and try to determine the change in
cerebral neovascularization by computation of the Q fac-
tor using vessel size imaging. The Q factor is a calculated
ratio that correlates with the degree of microvessel density
(MVD) [19,28]. Additionally, a MRI-based determination
of the intra-abdominal fat mass will be performed on all
patients with the second MRI scan after intervention. We
will furthermore analyze the association of observed
changes in blood biomarker levels with MRI findings and
functional outcomes of patients.
Sample size and power calculation
We chose a two-stage study design. After recruitment of
the first 24 patients an interim analysis will be per-
formed (first stage). The two-stage approach will give us
the opportunity to generate a more specified hypothesis
and evaluate the most pertinent biomarkers in more de-
tail and conduct the study with recruitment of up to 76
remaining patients (second stage).
Based on animal studies reporting a training-induced
CBF increase [20] we expect CBF to increase about 30%
after the 4-weeks intervention of physical exercise. The
PHYS-STROKE trial is aiming to recruit 215 patients.
Due to the stricter inclusion criteria of BAPTISe (ische-
mic stroke, MRI eligibility) we estimate that approxi-
mately 50% of all PHYS-STROKE patients can be
included in BAPTISe. Including 100 patients and allow-
ing for a 20% drop-out/loss to follow-up rate, the num-
ber of patients to be analyzed would be 80. With a
sample size of 80 patients (40 in each group) it is pos-
sible to detect differential changes between groups with
a power of 80% and a significance level alpha of 0.05 if
the effect size is 0.64. Since this is an exploratory study
no adjustment for multiple testing will be applied.
Patient population - inclusion and exclusion criteria
Patients (male/female) enrolled in PHYS-STROKE aged
18 years or older with ischemic stroke in the subacute
phase (5–45 days after onset) are eligible to participate
in BAPTISe. In addition to patients’ ability to perform
aerobic exercise, determined by the responsible phys-
ician, they must be able to undergo MRI scans. For all
inclusion and exclusion criteria please refer to “inclusion
and exclusion criteria of BAPTISe” section. Screening,
recruitment, baseline assessment, and follow-up visits
will take place at the recruiting rehabilitation sites in theBerlin area. MR imaging will take place at the Charité -
Universitätsmedizin Berlin.
Inclusion criteria
– Age: > 18 years
– Diagnosis of subacute ischemic stroke (within 5–45
days after stroke onset) as determined by initial
MRI/CT scan of the brain
– Cortical, sub-cortical, or brainstem affection
– Barthel Index (BI) <65 at inclusion
– Able to sit for at least 30 seconds (unsupported or
supported, i.e., holding onto supports such as the
edge of the bed)
– Ability to perform aerobic exercise, determined by
responsible physician
– Provision of written informed consent
Exclusion criteria
– Lacking ability to comply with study requirements
– Stroke due to intracranial hemorrhage
– Previous subarachnoid hemorrhage or other
hemorrhagic stroke
– Progressive stroke
– Not able to receive magnetic resonance imaging
scans, including perfusion imaging
– Unable to perform the required exercises due to
medical, musculo-skeletal, or neurological problems
– Required help of at least 1 person to walk before
stroke due to neurological (e.g., advanced
Parkinson’s disease, Amyotrophic Lateral Sclerosis,
Multiple Sclerosis) or non neurological co-
morbidities (e.g. heart failure, orthopedic problems)
– Life expectancy < 1 year as determined by
responsible physician
– Drug or alcohol addiction within the last six months
– Significant current psychiatric illness defined as
medication-refractory of bipolar affective disorder,
psychosis, schizophrenia or suicidality
– Current participation in another interventional trial
We will use convenience sampling of participants in
the PHYS-STROKE trial. Informed consent for both
studies is obtained simultaneously. After informed con-
sent for PHYS-STROKE and BAPTISe is obtained par-
ticipating patients will be randomized 1:1 either to the
experimental interventional group (physical fitness train-
ing) or to the control interventional group (relaxation)
of PHYS-STROKE, as shown in the Flow Chart in
Figure 1.
BAPTISe examines a subgroup within a randomized
controlled trial, PHYS-STROKE (details of the interven-
tion are described elsewhere; NCT01953549). In brief,
patients in the interventional arm of the PHYS-STROKE
trial will participate in a 4-week physical training course.
The physical training includes aerobic training for












Glucose X X X X
HbA1c X X X X
INR X
PTT X
Fibrinogen X X X X
LDL X X X X
HDL X X X X
Triglycerides X X X X
Lipoprotein a X X X X
Full blood
count
X X X X
Transaminases X X X X
Creatinine X X X X
Cortisol X X X X








hs-CRP X X X X
TNF-alpha X X X X
IL-6 X X X X




LBP X X X
MBL X X X
Copeptin X X X
proANP X X X
IL-1b RS RS RS RS
BDNF RS RS RS RS
IGF-1 RS RS RS RS
IGFBP-3 RS RS RS RS
G-CSF RS RS RS RS
NGF RS RS RS RS
Endothelial
progenitor cells
RS RS RS RS
Endothelial
microparticles
RS RS RS RS
Endoglin RS RS RS RS
Apelin RS RS RS RS
Table 1 List of tested blood biomarkers (Continued)
Irisin RS RS RS RS
CNTF RS RS RS RS
GFAP RS RS RS RS
VEGF RS RS RS RS
VEGFR RS RS RS RS
Other RS RS RS RS
Spectrum of blood biomarkers assessed in the first 24 patients. Parameters
which have proved to be most pertinent will be further evaluated in the
following patients of BAPTISe.
X = biomarker detection; (X) = detection if TSH is abnormal; RS = reserve
samples for later testing. HbA1c: glycated hemoglobin; INR: international
normalized ration; PTT: partial thromboplastin time; LDL: low-density lipoprotein;
HDL: high-density lipoprotein; TSH: thyreotropin; fT3: triiodothyronine;
fT4: thyroxine; FSH: follicle-stimulating hormone; LH: luteinizing hormone;
TNF-alpha: tumor necrosis factor alpha; IL-6: interleukin-6; HLA-DR: human
leucocyte antigen-DR; LBP: lipopolysaccharide-binding protein; MBL:
mannose-binding lectin; pro-ANP: pro-atrial natriuretic peptide BDNF: brain-
derived neurotrophic factor; IGF-1: insulin-like growth factor 1; IGFBP-3:
insulin-like growth factor-binding protein 3; G-CSF: granulocyte colony-
stimulating factor; CNTF: ciliary neurotrophic factor; GFAP: glial fibrillary
acidic protein; VEGF: vascular endothelial growth factor; VEGFR: vascular
endothelial growth factor receptor.
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of 20 sessions, in addition to standard rehabilitative
treatment. Patients in the control arm will take part in
relaxation sessions additionally to the standard rehabili-
tative treatment.
Observation
All patients enrolled in the PHYS-STROKE trial will
have blood draws before and after the intervention, and
at follow-up visits at 3 and 6 months post stroke (as part
of the PHYS-STROKE trial) to determine biomarkers
levels of immunity, inflammation, endothelial function,
and lipometabolism, considered relevant in (recurrent)
stroke [24,26,29-32]. A list of tested blood-derived bio-
markers is provided in Table 1. Patients of both groups
(intervention/control) who have also consented to par-
ticipate in BAPTISe will receive a cerebral MRI scan and
an additional blood draw for the assessment of markers
of endothelial function in the vicinity of the MR scanner
before and after the PHYS-STROKE intervention. The
MRI is performed in order to assess the degree of cerebral
perfusion changes and changes of the cerebral microvascu-
lature using vessel size imaging – a technique to quantita-
tively map the cerebral microvascular morphology [28,33].
Various parameters of perfusion and vascularization in-
cluding cerebral blood flow (CBF), cerebral blood volume
(CBV), microvessel density (Q factor), and vessel size
index (VSI) will be measured. Previous preclinical and
clinical studies have underscored the useful potential of
these imaging biomarkers in monitoring post-ischemic
brain tissue processes, such as angiogenesis and vascular
remodeling [18,19,28,33,34]. Imaging will be performed
with a 3 Tesla Siemens TIM Trio at the Department for
Patients enrolled in 
PHYS-Stroke (n = 215)
Patients eligble for the




MRI scan + 
blood biomarkers
MRI scan + 
blood biomarkers
4-weeks of physical
fitness training (n = 50)
4-weeks of relaxation
courses (n = 50)
MRI scan + 
blood biomarkers
MRI scan + 
blood biomarkers
Clinical follow-up within PHYS-Stroke
(n = 100)
Figure 1 Flow chart of the BAPTISe trial.
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complete MRI sequence protocol is listed in Table 2.Outcomes
The exploratory study design of BAPTISe will allow us
to generate a specified hypothesis and narrow down the
study endpoints after the analysis of data from the first
24 patients. We will analyze the association of primary
and secondary endpoints which are specified after the
interim analysis with functional outcome, in particular
Barthel Index (BI), walking speed (co-primary endpoints
of PHYS-STROKE), and modified Rankin Scale (mRS).
For imaging sequences see Table 2, which includes
cerebral blood flow (CBF) and cerebral blood volumeTable 2 MRI sequences
# Sequence name Details
(1) T2 abdominal T
1 Localizer 3 × 3
2 FLAIR 5 mm slice t
3 Resting state 3 × 3 × 4 m
4 DTI 64 directions
5 MPRAGE 1 mm isovox
6 MRA TOF, 0.5 × 0.
7 T1 2D FLASH, fl
8 DWI 6 directions,
- contrast applicatio
9 VSI / PWI combined SE
10 T1 2D FLASH, fl(CBV), vessel size imaging, and computation of the Q
factor to assess cerebral microvessel density (MVD). The
assessment of the intra-abdominal fat mass of patients
will only be performed with the second MRI scan after
intervention. Changes of pertinent blood biomarker levels
listed in Table 1 will be correlated with MRI changes, next
cerebrovascular events, and functional status directly after
the intervention and 3 months post stroke.Data monitoring body
Adverse events emerging in the PHYS-STROKE trial are
registered within 24 hours of occurrence and immediately
reported to the study physician. Data Safety and Monitor-
ing Board (DSMB) is informed of all serious adverse events
and study progress.Statistical analysis
Based on feasibility of data collection the final sample
size will include up to 80–100 patients.
Differential changes in measures between groups from
baseline to follow up (4 weeks, 3 months, and 6 months)
will be analyzed separately for every measure using
ANCOVA with baseline measures and exposure (physical
training) as covariates and follow up measure as outcome.
In further analyses it will be accounted for additional
covariates such as age, sex, stroke severity, and diffusion-
weighted imaging (DWI) lesion volume. In order to analyze
the complete longitudinal course of the data linear mixed
effects models will be used for the analysis.
Additionally we will analyze how changes in MRI mea-
sures and blood markers are related to each other and to
differences in functional outcome, in particular gait speed,
Barthel index (co-primary endpoints of PHYS-STROKE)
and mRS, after adjustment for treatment exposure using
appropriate statistical methods.Duration
SE with water suppression (only 2nd scan) 2:13
0:11
hickness 1:54
m × 150 scans, TR = 2.3 s 6:44
plus 9× B0, 2.3 mm isovoxel 10:04
el 4:26
5 × 0.7 mm 2:53
ip angles 25°/50° 0:40
5 mm slice thickness 1:30
n (gadobutrol) -
-GRE, TE = 22 ms/85 ms 2:31
ip angles 25°/50° 0:40
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The aim of the interim analysis of the first 24 recruited
patients is to confirm feasibility and update the analysis
plan, identifying the most promising primary endpoint
and excluding less promising blood markers from fur-
ther analysis that are not associated with the exposure
(physical training) defined by effect sizes for differential
changes between groups of less than 0.3.
Sensitivity analysis
We will compare baseline characteristics (age, sex, stroke
severity, DWI lesion size) between those patients included
in BAPTISe and eligible patients in PHYS-STROKE
who were not included in BAPTISE to test if patients in
BAPTISe are comparable to the study population in
PHYS-STROKE.
Study organization and funding
BAPTISe is funded by the Federal Ministry of Education
and Research through the grant G.2.15 of the Center for
Stroke Research Berlin (CSB).
Discussion
The goal of this clinical study is to show that physical
fitness training of patients in the subacute phase of ische-
mic stroke leads to changes in imaging and blood-derived
biomarkers which correlate with improved functional out-
come. The study will provide important information about
the roles of imaging and blood biomarkers in subacute
stroke rehabilitation. It thus might impact current rehabili-
tation strategies representing advantageous methods of
monitoring future treatment plans that address the pro-
motion of cerebral perfusion and neovascularization after
stroke.
Trial status
Patient recruitment will start in October 2013 and is
aimed to continue for 30 months in total. Last follow-up
is scheduled for October 2016.
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